Bozinoff N, Small W, Long C, DeBeck K, Fast D Still "at risk": an examination of how street-involved young people understand, experience, and engage with "harm reduction" in Vancouver's inner city Int J Drug Policy, 2017. PubMed

Goodman A, Fleming K, Markwick N, Morrison T, Lagimodiere L, Kerr T; Western Aboriginal Harm Reduction Society Corrigendum to "They treated me like crap and I know it was because I was Native": the healthcare experiences of Aboriginal peoples living in Vancouver's inner city Soc Sci Med, 2017. PubMed

Socías ME, Wood E, McNeil R, Kerr T, Dong H, Shoveller J, Montaner J, Milloy MJ Unintended impacts of regulatory changes to British Columbia Methadone Maintenance Program on addiction and HIV-related outcomes: an interrupted time series analysis Int J Drug Policy, 2017. PubMed

Ti L, Lima V, Hull M, Nosyk B, Joy J, Montaner J, Krajden M, Harrigan R, Kerr T, Shannon K, Wood E, Shoveller J, Ramji A, Ko HH, Yoshida E, Hall D, Barrios R Hepatitis C testing in Canada: don’t leave baby boomers behind CMAJ, 2017. PubMed

Barker B, Goodman A, DeBeck K Reclaiming Indigenous identities: culture as strength against suicide among Indigenous youth in Canada Can J Public Health, 2017. PubMed

Boyd J, Fast D, Hobbins M, McNeil R, Small W Social-structural factors influencing periods of injection cessation among marginalized youth who inject drugs in Vancouver, Canada: an ethno-epidemiological study Harm Reduct J, 2017. PubMed

Fast D, Shoveller J, Kerr T The material, moral, and affective worlds of dealing and crime among young men entrenched in an inner city drug scene Int J Drug Policy, 2017. PubMed

Socías ME, Duff P, Shoveller J, Montaner JSG, Nguyen P, Ogilvie G, Shannon K Use of injectable hormonal contraception and HSV-2 acquisition in a cohort of female sex workers in Vancouver, Canada Sex Transm Infect, 2017. PubMed

Ti L, Milloy MJ, Turje RB, Montaner J, Wood E, Kerr T The impact of an HIV/AIDS adult integrated health program on leaving hospital against medical advice among HIV-positive people who use illicit drugs J Public Health (Oxf), 2017. PubMed

Korthuis PT, Lum PJ, Vergara-Rodriguez P, Ahamad K, Wood E, Kunkel LE, Oden NL, Lindblad R, Sorensen JL, Arenas V, Ha D, Mandler RN, McCarty D, CTN-0055 CHOICES Investigators Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trial Addiction, 2017. PubMed